Hospital Universitary General de Catalunya, is a Private Hospital in Sant Cugat del Vallés, Barcelona, Catalonia. Whilst the hospital offically does not especify in any medical field, the Hospital is one of the highest rated in Catalonia for General Surgery.

There are 300 beds in Hospital General de Catalunya.

During the past decade, Hospital General de Catalunya conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 23 clinical trials were completed, i.e. on average, 39% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 19 clinical trials were completed. i.e. 67.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General de Catalunya" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "SOLTI Breast Cancer Research Group" with 6 trials sponsored, "Pfizer" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Impax Laboratories, LLC" with 3 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General de Catalunya" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "ClinSearch" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator and "Novartis" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General de Catalunya" are "Parkinson's Disease" (6 trials), "Alzheimer Disease" (5 trials), "Alzheimer's Disease" (4 trials), "Breast Cancer" (4 trials) and "Diabetic Retinopathy" (4 trials). Many other conditions were trialed in "Hospital General de Catalunya" in a lesser frequency.

Most popular intervention types in "Hospital General de Catalunya" are "Drug" (53 trials), "Other" (12 trials), "Biological" (9 trials), "Procedure" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Faricimab" (5 trials), "Sham Procedure" (5 trials), "Aflibercept" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General de Catalunya" are 63 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital General de Catalunya". undefined are not yet recruiting, 12 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Hospital General de Catalunya, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General de Catalunya, 0 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Hospital General de Catalunya has several departments that took part in Clinical trials: "Hospital General De Catalunya; Servicio de Neurologia" - 8 trials